FDA Inspection
Eurofins Pharma Quality ControlEurofins Pharma Quality Control – FDA Inspection, Mar 17, 2022
Record Details
This FDA Inspection record concerns Eurofins Pharma Quality Control, with an inspection on March 17, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 17, 2022
- Product Type
- Drugs
View Company Profile
ID · 676663b5-a837-48c0-a064-3967badfbfd4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1240850
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eurofins Pharma Quality Control
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins Pharma Quality Control
- FDA Inspection 1091920 - 2017-09-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.